Central America Investment Opportunities Pharmaceuticals: Risk/Reward Analysis

Geographic diversification may be a favourable strategy for multinational pharmaceutical companies, but it is vital that firms recognise both the rewards and the risks present in a market, whether developed or emerging. BMI's Risk/Rewards Ratings (RRR) tool, which provides a globally comparative and numerically based assessment of a market's attractiveness, was established to address this. In BMI's Q413 RRRs, the Americas region scores 51 out of 100, compared to Western Europe (67), Central and Eastern Europe (52) Middle East and Africa (42) and Asia Pacific (53).

Download your FREE whitepaper


Download your FREE whitepaper

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

You will shortly receive your free whitepaper by email.